We are live on ! Find out more
PBE icon

Invesco Biotechnology & Genome ETF
PBE

86 hedge funds and large institutions have $170M invested in Invesco Biotechnology & Genome ETF in 2015 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 21

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

3% more capital invested

Capital invested by funds: $165M → $170M (+$4.84M)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0.26% less ownership

Funds ownership: 30.76% → 30.5% (-0.26%)

1% less funds holding

Funds holding: 87 → 86 (-1)

Holders
86
Holders Change
-1
Holders Change %
-1.15%
% of All Funds
2.32%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
25
Reduced
21
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wells Fargo
Wells Fargo
California
+$1.67M
2
Bank of America
Bank of America
North Carolina
+$989K
3
LPL Financial
LPL Financial
California
+$669K
4
QA
Quantitative Advantage
Minnesota
+$594K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$371K

Top Sellers

Rank Fund Capital Flow
1
Jane Street
Jane Street
New York
-$2.46M
2
Citadel Advisors
Citadel Advisors
Florida
-$1.64M
3
AIG
American International Group
New York
-$1.16M
4
Morgan Stanley
Morgan Stanley
New York
-$972K
5
VF
Virtu Financial
New York
-$698K
Name Holding Trade Value Shares
Change 		Change in
Stake
CWM
26
Concert Wealth Management
California
$1.22M – – –
OPCM
27
Osborne Partners Capital Management
California
$1.05M – – –
Envestnet Asset Management
28
Envestnet Asset Management
Illinois
$904K -$13.8K -242 -2%
MAA
29
Managed Account Advisors
New Jersey
$904K +$63.5K +1,110 +8%
Ameriprise
30
Ameriprise
Minnesota
$767K -$72.8K -1,274 -9%
WB
31
Webster Bank
Connecticut
$744K -$45.2K -790 -6%
BPC
32
Banque Pictet & Cie
Switzerland
$688K – – –
Janney Montgomery Scott
33
Janney Montgomery Scott
Pennsylvania
$662K +$3.43K +60 +0.5%
VF
34
Virtu Financial
New York
$653K -$698K -12,200 -52%
Citigroup
35
Citigroup
New York
$601K +$51.5K +901 +10%
AIG
36
American International Group
New York
$555K -$1.16M -20,247 -68%
CFS
37
Commonwealth Financial Services
West Virginia
$538K – – –
Neuberger Berman Group
38
Neuberger Berman Group
New York
$442K – – –
JIC
39
Joel Isaacson & Co
New York
$402K – – –
CIC
40
Carnegie Investment Counsel
Ohio
$400K +$57 +1 +0%
LTFS
41
Ladenburg Thalmann Financial Services
Florida
$370K -$37.3K -653 -9%
ICAS
42
Investors Capital Advisory Services
Massachusetts
$349K +$12.9K +225 +4%
PJSIMP
43
P.J. Schmidt Investment Management (PJS)
Wisconsin
$344K -$4.86K -85 -1%
BRWA
44
B. Riley Wealth Advisors
Florida
$337K +$330K +5,767 New
Mirae Asset Global Investments
45
Mirae Asset Global Investments
South Korea
$327K -$5.72K -100 -2%
Baird Financial Group
46
Baird Financial Group
Wisconsin
$301K +$295K +5,158 New
CAN
47
Cetera Advisor Networks
California
$297K – – –
PPA
48
Parametric Portfolio Associates
Washington
$294K +$288K +5,031 New
WA
49
WBH Advisory
Maryland
$289K +$57 +1 +0%
Millennium Management
50
Millennium Management
New York
$273K -$408K -7,138 -60%
1
2
3 4

PBE Hedge Fund Activity: Q2 2015 in Review

86 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Invesco Biotechnology & Genome ETF (PBE) for Q2 2015, worth a combined $170M — up 2.9% from $165M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new PBE positions and 10 closed out — a net gain of 1 holder — while 25 added to existing stakes and 21 trimmed.

The largest buyer was Wells Fargo, adding an estimated $1.67M. The largest seller was Jane Street, exiting entirely with an estimated $2.46M sold.

  • 86 institutional investors held Invesco Biotechnology & Genome ETF (PBE) as of Q2 2015, down from 87 in Q1 2015.
  • Funds reported $170M of Invesco Biotechnology & Genome ETF stock for Q2 2015, up 2.9% quarter-over-quarter.
  • 11 funds opened new Invesco Biotechnology & Genome ETF positions in Q2 2015 and 10 closed out, a net change of +1 holder.
  • The largest Invesco Biotechnology & Genome ETF buyer in Q2 2015 was Wells Fargo, an estimated $1.67M added.
  • The largest Invesco Biotechnology & Genome ETF seller in Q2 2015 was Jane Street, an estimated $2.46M sold.

Based on aggregated 13F filings for Q2 2015.